-+ 0.00%
-+ 0.00%
-+ 0.00%

Valneva Reports Four-Year Durability of Single-Dose Chikungunya Vaccine IXCHIQ® With 95% Seroresponse in Adults

Reuters·09/30/2025 05:00:25

Please log in to view news